longevitydocs. Rooms™ are live audio conversations on longevitydocs.ai. Twenty-minute peer-led sessions where longevity physicians host and join focused discussions, asking questions, sparking debate, and sharing clinical insights in real time.
Access is limited to verified MDs and DOs and members of longevitydocs.™ These conversations move faster than journals. The physicians below joined is for recent programming, here's what they shared.
Dr. Neil Panchal, MD · Anatomy of a Longevity AI Agent
Dr. Neil Panchal, Chief Medical Officer, Longevitex · CEO, Concierge Longevity Medicine
Dr. Panchal transitioned from emergency medicine into longevity practice seven years ago, building AI-augmented workflows at Longevitex. He reframes agent-building for non-coder physicians: the right tool is the one you'll actually use and maintain, and workflow automation begins with documenting decision rules in plain language—not code.
Key Insights
- The first two agents every longevity practice should build are a deep research agent (background scraping of PubMed, Nature, and clinical trial registries) and a business operations agent. Custom clinical agents come later, not first.
- Treat each AI agent as an employee with one job, overseen by a nurse who synthesizes outputs before clinical review. The residency training model is the right mental model, not the autopilot model.
- The cost-benefit calculation flips at a tipping point of 3 to 5 tools. Beyond that, token costs, fragmentation, and staff retraining make outsourcing to a vetted HIPAA-grade platform (Open Evidence, ChatGPT Clinician, Amazon HealthAI, Perplexity Health) the rational move.
"The right tool is the one you'll actually use and maintain. Think of each AI agent as an employee with one job, overseen by a human, and design your workflows so humans do only the work machines cannot: judgment, presence, and synthesis." — Dr. Neil Panchal, MD
Dr. Jordan Emont, MD, MPH · HRT After Breast Cancer
Dr. Jordan Emont, OBGYN, Menopause Society Certified · Founder, Meridian Medical
Dr. Emont trained at Brown for medical school and Columbia for residency, with graduate degrees in public health and epidemiology from Yale. He founded Meridian Medical to deliver evidence-informed, individualized HRT conversations to breast cancer survivors who have been routinely denied treatment based on outdated trial data.
Key Insights
- The blanket contraindication against HRT for breast cancer survivors is built on outdated trials using synthetic progestins and inconsistent methodology. The Stockholm 10-year follow-up shows no increased recurrence in ER-positive patients on concurrent tamoxifen, and Valiopoulos shows no increased recurrence with estrogen-only therapy in ER-negative patients.
- Survivors forced into early menopause by cancer treatment face greater long-term mortality from cardiovascular disease and osteoporosis than from cancer recurrence, yet are routinely denied symptom-management options.
- Modern risk stratification uses receptor status, concurrent endocrine therapy, and tumor genetics (Breast Cancer Index, Oncotype, circulating tumor DNA) to individualize the conversation. Duavee, vaginal estrogen, testosterone, and neurokinin antagonists each have a defined role in the modern toolkit.
"Breast cancer survivors are routinely denied HRT on the basis of outdated trial data using synthetic progestins and poor methodology. The modern evidence permits an evidence-informed, individualized conversation, and patient autonomy and quality of life must anchor it." — Dr. Jordan Emont, MD, MPH
Dr. JonathanN Kuo, MD · Latest Advances in Longevity Medicine
Dr. Jonathann Kuo, Founder & CEO, Extension Health
Dr. Kuo is double board-certified in anesthesiology and pain management with seven years of practice in longevity medicine in New York. He maintains close working relationships with underground biohacker and bodybuilder communities for real-world safety data, allowing Extension Health to evaluate emerging technologies that traditional practices cannot.
Key Insights
- The fastest knowledge transfer in longevity medicine is not happening in peer-reviewed journals. It is happening on Instagram, X, Substack, and inside closed peptide and biohacker communities, months to years ahead of publication.
- Extended-release peptide engineering (FLGR242 and albumin-bound formulations) is collapsing dosing from five times daily to weekly or biweekly, reshaping what physicians can realistically prescribe and patients can realistically adhere to.
- Functional MRI with spectroscopy paired with 3D-printed neuromasks now allows focused transcranial ultrasound delivery of exosomes, stem cells, peptides, or cerebrolysin directly to the hypothalamus, opening a path to restoring function without lifelong GHR/GHRP protocols.
"The fastest path to the bleeding edge is through the people who are already there. Follow the right physicians, chemists, and practitioners on the right platforms, and you'll be operating two years ahead of what gets published in the journals." — Dr. Jonathann Kuo, MD
Dr. Catherine Johnson, MD · Perimenopausal Weight Loss Resistance
Dr. Catherine Johnson, Triple Board-Certified · Obesity Medicine & Menopause
Dr. Johnson operates a concierge practice anchored in obesity medicine and menopause certification, reframing perimenopause not as a cosmetic problem but as a precision diagnostic window. She frames the perimenopausal woman's weight gain as a systems-level metabolic and neuroendocrine crisis, not a discipline failure.
Key Insights
- Perimenopausal weight gain is a neuroendocrine cascade, not a discipline failure. Approximately two years before the final menstrual period, the rate of fat gain doubles. Estrogen and progesterone chaos fractures sleep, elevates fasting glucose, drives insulin resistance, and pushes body composition toward visceral fat.
- BMI underestimates the true picture. HOMA-IR, percentage body fat (≥30% marks overweight regardless of BMI), and screening for Hashimoto's (present in 20% of perimenopausal women) catch the patients standard panels miss.
- Get cortisol down, progesterone in, nutrients optimized, and sleep protected before demanding exercise. Exercise sabotages weight loss in the first six weeks when cortisol is high, ferritin is low, and the patient is exhausted. Progesterone first. Estrogen last.
"40% of a woman's life is lived postmenopausally, and her trajectory is being written now. Treat her as a composite of neuroendocrine, metabolic, and inflammatory dysfunction. Show her the data, validate her experience, and she will refer your entire network." — Dr. Catherine Johnson, MD
Dr. Jijoe Joseph, MD, DO, MBA · The Future of Cognitive Longevity
Dr. Jijoe Joseph. Emergency Medicine · Founder, IGERA Health
Dr. Joseph is an emergency medicine physician and founder of IGERA Health, a precision medicine center in New Jersey. His entry into longevity medicine stemmed from recognizing burnout in emergency medicine—where the average mortality age is 59—and pivoting toward preventive care anchored in cognitive longevity research.
Key Insights
- Alzheimer's is a measurement problem, not a screening problem. The disease develops silently for 15 to 20 years before symptoms appear, and p-tau-217 paired with GFAP, NFL, amyloid 42/40, and ApoE now gives a 15- to 20-year predictive lead time. The Washington University "p-tau-217 clock" can estimate whether a 55-year-old will present at 70 or 90.
- Single-agent drugs fail in symptomatic disease, but the evidence converges on layered intervention. The EVOKE semaglutide trial failed in 3,000+ patients, while Ornish's lifestyle protocol improved cognition in 71% of early Alzheimer's patients and the CETP inhibitor obocytrapib became the first single agent to move every neurodegenerative biomarker favorably.
- Cognitive longevity begins at 50 with measurement, not at 75 with rescue. Build a brain-aging dashboard first (p-tau-217 + GFAP + NFL + amyloid ratio + ApoE), then layer in a lifestyle foundation, autophagy support (rapamycin, cerebrolysin), signaling peptides, and adjunctive modalities (TPE, hyperbaric oxygen, red light) matched to individual biology.
"Alzheimer's disease is not a screening problem but a measurement problem. The 20-year presymptomatic window now revealed by p-tau-217 blood biomarkers is a genuine intervention opportunity, provided you begin before symptoms appear. Cognitive longevity is not a late-stage problem. It begins at age 50 with measurement and prevention, not at 75 with symptomatic rescue." — Dr. Jijoe Joseph, MD, DO, MBA
JOIN THE LONGEVITY PHYSICIAN COMMUNITY JOIN OUR COMMUNITY TO ACCESS longevitydocs Rooms™ Apply for membership to join 1,000+ physicians across 50+ countries.
FAQ
What are longevitydocs Rooms™?
longevitydocs.™ Rooms are live peer to peer audio conversations on longevitydocs.ai where longevity physicians host and join 20-minute peer-led discussions. You listen, contribute, and walk away with clinical insights and evidence-based protocols. all within a verified physician-only community.
How do I join a longevitydocs Rooms™?
If you're already on longevitydocs.ai, head to Chat at the appointed time. If you're a community member not yet on the platform, create your account at longevitydocs.ai/join/group. If you're not yet a member, apply at longevitydocs.org/pages/membership.
Can I watch recordings if I miss a live session?
No. That's the point. What happens in the room stays in the room. Session recaps and key takeaways are featured on our social media channels but the best place to get live support is inside the platform.
Who can access Rooms?
Rooms are open to vetted MDs and DOs only. Access is limited to the longevity physician community to maintain the clinical rigor and confidentiality of peer-led discussions.
Why twenty minutes?
The format is purpose-built for busy physicians. Twenty minutes forces conversations to stay focused and actionable no meandering intros, no filler content. You get straight to the clinical takeaways that change how you practice.
When are new Rooms scheduled?
New Rooms are added weekly throughout the year. Programming is published on the longevitydocs.ai platform so you can plan ahead and join the sessions most relevant to your practice.
Is there a cost to join Rooms?
Rooms access is included with longevitydocs membership.
About Dr. David Luu Dr. David Luu, MD, is the Founder of longevitydocs™. He is a trained pediatric cardiac surgeon, longevity tech entrepreneur, and philanthropist who helps physicians, organizations, and leaders build the global infrastructure of longevity medicine. About longevitydocs™ longevitydocs.™ is the world's leading longevity physician community. Over 1,000 physicians across 68+ countries united by one conviction: every doctor should be a longevity doctor. We build the infrastructure, education, and community physicians need to make longevity medicine their default practice.
Longevitydocs. Rooms™ with 5 Longevity Doctors Shaping the Future
ROOMS
longevitydocs.Rooms™ with 5 Longevity Doctors Shaping the Future
The cutting edge of longevity medicine happens in 20 minute peer to peer conversations. Here's what Dr. Neil Panchal, Dr. Jordan Emont, Dr. Jonathann Kuo, Dr. Catherine Johnson, and Dr. Jijoe Joseph shared in longevitydocs. Rooms™ this past month.
longevitydocs. Rooms™ are live audio conversations on longevitydocs.ai. Twenty-minute peer-led sessions where longevity physicians host and join focused discussions, asking questions, sparking debate, and sharing clinical insights in real time.
Access is limited to verified MDs and DOs and members of longevitydocs.™ These conversations move faster than journals. The physicians below joined is for recent programming, here's what they shared.
Dr. Neil Panchal, MD · Anatomy of a Longevity AI Agent
Dr. Neil Panchal, Chief Medical Officer, Longevitex · CEO, Concierge Longevity Medicine
Dr. Panchal transitioned from emergency medicine into longevity practice seven years ago, building AI-augmented workflows at Longevitex. He reframes agent-building for non-coder physicians: the right tool is the one you'll actually use and maintain, and workflow automation begins with documenting decision rules in plain language—not code.
Key Insights
Dr. Jordan Emont, MD, MPH · HRT After Breast Cancer
Dr. Jordan Emont, OBGYN, Menopause Society Certified · Founder, Meridian Medical
Dr. Emont trained at Brown for medical school and Columbia for residency, with graduate degrees in public health and epidemiology from Yale. He founded Meridian Medical to deliver evidence-informed, individualized HRT conversations to breast cancer survivors who have been routinely denied treatment based on outdated trial data.
Key Insights
Dr. JonathanN Kuo, MD · Latest Advances in Longevity Medicine
Dr. Jonathann Kuo, Founder & CEO, Extension Health
Dr. Kuo is double board-certified in anesthesiology and pain management with seven years of practice in longevity medicine in New York. He maintains close working relationships with underground biohacker and bodybuilder communities for real-world safety data, allowing Extension Health to evaluate emerging technologies that traditional practices cannot.
Key Insights
Dr. Catherine Johnson, MD · Perimenopausal Weight Loss Resistance
Dr. Catherine Johnson, Triple Board-Certified · Obesity Medicine & Menopause
Dr. Johnson operates a concierge practice anchored in obesity medicine and menopause certification, reframing perimenopause not as a cosmetic problem but as a precision diagnostic window. She frames the perimenopausal woman's weight gain as a systems-level metabolic and neuroendocrine crisis, not a discipline failure.
Key Insights
Dr. Jijoe Joseph, MD, DO, MBA · The Future of Cognitive Longevity
Dr. Jijoe Joseph. Emergency Medicine · Founder, IGERA Health
Dr. Joseph is an emergency medicine physician and founder of IGERA Health, a precision medicine center in New Jersey. His entry into longevity medicine stemmed from recognizing burnout in emergency medicine—where the average mortality age is 59—and pivoting toward preventive care anchored in cognitive longevity research.
Key Insights
FAQ
What are longevitydocs Rooms™?
longevitydocs.™ Rooms are live peer to peer audio conversations on longevitydocs.ai where longevity physicians host and join 20-minute peer-led discussions. You listen, contribute, and walk away with clinical insights and evidence-based protocols. all within a verified physician-only community.
How do I join a longevitydocs Rooms™?
If you're already on longevitydocs.ai, head to Chat at the appointed time. If you're a community member not yet on the platform, create your account at longevitydocs.ai/join/group. If you're not yet a member, apply at longevitydocs.org/pages/membership.
Can I watch recordings if I miss a live session?
No. That's the point. What happens in the room stays in the room. Session recaps and key takeaways are featured on our social media channels but the best place to get live support is inside the platform.
Who can access Rooms?
Rooms are open to vetted MDs and DOs only. Access is limited to the longevity physician community to maintain the clinical rigor and confidentiality of peer-led discussions.
Why twenty minutes?
The format is purpose-built for busy physicians. Twenty minutes forces conversations to stay focused and actionable no meandering intros, no filler content. You get straight to the clinical takeaways that change how you practice.
When are new Rooms scheduled?
New Rooms are added weekly throughout the year. Programming is published on the longevitydocs.ai platform so you can plan ahead and join the sessions most relevant to your practice.
Is there a cost to join Rooms?
Rooms access is included with longevitydocs membership.
This article is published exclusively for licensed healthcare professionals. It is not intended for consumers or patients.
All content is for continuing medical education and professional information purposes. It reflects emerging research, science, and technology with implications for medical practice. It does not constitute medical advice, clinical recommendations, or treatment guidance for any individual patient.
By reading, you confirm you are a licensed healthcare professional and will apply this information within your clinical judgment, professional obligations, and applicable regulations.